ENTRY       D10094                      Drug
NAME        Blosozumab (USAN)
FORMULA     C6424H9852N1684O2030S46
EXACT_MASS  144538.6608
MOL_WEIGHT  144628.0165
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGASVKV SCKVSGFPIK DTFQHWVRQA PGKGLEWMGW SDPEIGDTEY
            ASKFQGRVTM TEDTSTDTAY MELSSLRSED TAVYYCATGD TTYKFDFWGQ GTTVTVSSAS
            TKGPSVFPLA PCSRSTSEST AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTKTYT CNVDHKPSNT KVDKRVESKY GPPCPPCPAP EFLGGPSVFL
            FPPKPKDTLM ISRTPEVTCV VVDVSQEDPE VQFNWYVDGV EVHNAKTKPR EEQFNSTYRV
            VSVLTVLHQD WLNGKEYKCK VSNKGLPSSI EKTISKAKGQ PREPQVYTLP PSQEEMTKNQ
            VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSRLTV DKSRWQEGNV
            FSCSVMHEAL HNHYTQKSLS LSLG
            (Light chain)
            DIQMTQSPSS LSASVGDRVT ITCKASQDVH TAVAWYQQKP GKAPKLLIYW ASTRWTGVPS
            RFSGSGSGTD FTLTISSLQP EDFATYYCQQ YSDYPWTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H132-L214, H145-H201, H224-H'224, H227-H'227, H259-H319, H365-H423, H'22-H'96, H'132-L'214, H'145-H'201, H'259-H'319, H'365-H'423, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Osteoporosis agent
  TYPE      Monoclonal antibody
COMMENT     Treatment of osteoporosis
TARGET      SOST [HSA:50964] [KO:K16834]
  PATHWAY   hsa04310(50964)  Wnt signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Not elsewhere classified
              Signaling molecules
               Wnt signaling
                SOST
                 D10094  Blosozumab (USAN)
DBLINKS     CAS: 1132758-87-2
            PubChem: 135626813
///
